Data as of Sep 19
| +0.03 / +0.03%|
The 22 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 111.00, with a high estimate of 165.00 and a low estimate of 76.00. The median estimate represents a +4.76% increase from the last price of 105.96.
The current consensus among 27 polled investment analysts is to Buy stock in Gilead Sciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.